Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | REN | P00797 | 8/20 | 0.67 |
| ▸ | CTSS | P25774 | 5/20 | 0.63 |
| ▸ | CTSK | P43235 | 4/20 | 0.63 |
| ▸ | CTSB | P07858 | 3/20 | 0.63 |
| ▸ | CTSL | P07711 | 2/20 | 0.63 |
| ▸ | AKT1 | P31749 | 1/20 | 0.61 |
| ▸ | PSEN1 | P49768 | 3/20 | 0.55 |
| ▸ | PSEN2 | P49810 | 3/20 | 0.55 |
| ▸ | APH1B | Q8WW43 | 3/20 | 0.55 |
| ▸ | NCSTN | Q92542 | 3/20 | 0.55 |
| ▸ | APH1A | Q96BI3 | 3/20 | 0.55 |
| ▸ | PSENEN | Q9NZ42 | 3/20 | 0.55 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3683727 | 1.00 | REN (0.67) | RENCTSSCTSKCTSBCTSL | |
| SCHEMBL5565889 | 0.91 | CTSS (0.74) | CTSSCTSKCTSBCTSLAKT1 | |
| SCHEMBL28969908 | 0.91 | CTSS (0.74) | CTSSCTSKCTSBCTSLAKT1 | |
| SCHEMBL7305781 | 0.89 | REN (0.69) | RENCTSSCTSKCTSBCTSL | |
| SCHEMBL9101385 | 0.88 | REN (0.73) | RENCTSSCTSKCTSBCTSL | |
| SCHEMBL6897460 | 0.88 | REN (0.73) | RENCTSSCTSKCTSBCTSL | |
| SCHEMBL5994686 | 0.88 | REN (0.73) | RENCTSSCTSKCTSBCTSL | |
| SCHEMBL9551232 | 0.88 | REN (0.73) | RENCTSSCTSKCTSBCTSL | |
| SCHEMBL9101393 | 0.88 | REN (0.73) | RENCTSSCTSKCTSBCTSL | |
| SCHEMBL3046634 | 0.88 | REN (0.73) | RENCTSSCTSKCTSBCTSL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8198364-B2 | Poly (vinyl alcohol) polymers, uses and preparation thereof | VALORISATION-RECHERCHE, LIMITED PARTNERSHIP (CA) | 2012-06-12 | — | — | US | disclosed |
| US-8198364-B2 | Poly (vinyl alcohol) polymers, uses and preparation thereof | VALORISATION-RECHERCHE, LIMITED PARTNERSHIP (CA) | 2012-06-12 | — | — | US | disclosed |
| US-20100038297-A1 | Poly (Vinyl Alcohol) Polymers, Uses and Preparation Thereof | UNIVERSITE DE MONTREAL (CA) | 2010-02-18 | — | — | US | disclosed |
| EP-2029644-A1 | POLY (VINYL ALCOHOL) POLYMERS, USES AND PREPARATION THEREOF | Valorisation-Recherche, Société en Commandite (CA) | 2009-03-04 | — | — | EP | disclosed |
| WO-2007143848-A1 | POLY (VINYL ALCOHOL) POLYMERS, USES AND PREPARATION THEREOF | Valorisation-Recherche, Société en Commandite (CA) | 2007-12-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100038297-A1 | Poly (Vinyl Alcohol) Polymers, Uses and Preparation Thereof | PUF60, VCL, PARG | REN 2541/4885CTSS 4658/4885CTSK 4392/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.